Home
Conditions
Central Nervous System Infections

Clinical trial condition

Central Nervous System Infections

Explore clinical trials studying Central Nervous System Infections. Study availability and eligibility vary by location and protocol.

746 public trials 77 recruiting studies

Refine in advanced search Browse all conditions

Central Nervous System Infections trial results

Completed

Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine When Co-administered With Routine Pediatric Vaccines in Healthy Infants and Toddlers in Europe

NCT03547271

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +11 more
Locations: Investigational Site Number : 2031006 Chlumec nad Cidlinou, Czechia

Investigational Site Number : 2031013 Domažlice, Czechia

Investigational Site Number : 2031010 Jindřichův Hradec, Czechia

Investigational Site Number : 2031012 Jindřichův Hradec, Czechia

View all 33 locations

View Trial Details

Completed

BIGlobal Intervention Study: Improving Diagnosis and Management of Suspected Brain Infections Globally

NCT04190303

Conditions: Abscess, Abscess Brain, Brain Abscess, +9 more
Locations: FioCruz Recife, Brazil

National Institute of Mental Health and Neurosciences Bangalore, India

Christian Medical College Vellore, India

Malawi Liverpool Wellcome Trust Blantyre, Malawi

View Trial Details

Completed

Intrathecal Therapy for Adult Tuberculous Meningitis: Impact on Clinical Outcomes

NCT06811792

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +15 more
Locations: Not specified

View Trial Details

Completed

Flavivirus Cross-priming Potential of IMOJEV

NCT03920111

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Liverpool University Hospitals NHS Foundation Trust Liverpool, United Kingdom

View Trial Details

Completed

A Study to Evaluate Safety and Immunogenicity of Sequential Vaccination of Sabin Inactivated Poliomyelitis Vaccine (Vero Cell) and Live Attenuated Poliomyelitis Vaccine in Healthy 2-month-old Infants

NCT06752174

Conditions: Central Nervous System Diseases, Central Nervous System Infections, Enterovirus Infections, +10 more
Locations: Shandong Provincial Center for Diseases Control and Prevention Jinan, Shandong, China

View Trial Details

Completed

Management of Tick-borne Encephalitis

NCT06593249

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +16 more
Locations: University Medical Centre Ljubljana, Ljublajana, Slovenia Ljubljana, Slovenia

View Trial Details

Completed

Familiar Fatal Insomnia: Preventive Treatment With Doxycycline in Subject With Disease Risk

NCT04846335

Conditions: Central Nervous System Diseases, Central Nervous System Infections, Dyssomnias, +9 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Safety and Immunogenicity of Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) in Healthy Adults

NCT06101173

Conditions: Central Nervous System Diseases, Central Nervous System Infections, Enterovirus Infections, +10 more
Locations: Nucleus Network Pty Ltd Geelong, Victoria, Australia

Nucleus Network Pty Ltd Melbourne, Victoria, Australia

View Trial Details

Completed

Efficacy of Platelet-Rich Plasma Versus Mesotherapy in Androgenetic Alopecia: A Retrospective Study

NCT05129800

Conditions: Alopecia, Androgenetic Alopecia, Central Nervous System Diseases, +17 more
Locations: Not specified

View Trial Details

Completed

Study of Novel Types 1 and 3 Oral Poliomyelitis Vaccines

NCT04529538

Conditions: Central Nervous System Diseases, Central Nervous System Infections, Enterovirus Infections, +10 more
Locations: Pharmaron CPC, Inc. Baltimore, Maryland, United States

Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States

University of North Carolina Institute for Global Health and Infectious Diseases (IGHID) Chapel Hill, North Carolina, United States

University of Vermont Vaccine Testing Center Burlington, Vermont, United States

View Trial Details

Central Nervous System Infections

Central Nervous System Infections trial results

Related conditions